Hongfeng Gou
Sichuan University(CN)
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, MicroRNA in disease regulation, Cancer Immunotherapy and Biomarkers, Sarcoma Diagnosis and Treatment
Most-Cited Works
- → An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells(2015)114 cited
- → p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells(2014)70 cited
- → Metabolic Reprogramming of Glycolysis, Lipids, and Amino Acids in Tumors: Impact on CD8 + T Cell Function and Targeted Therapeutic Strategies(2025)14 cited
- → Tislelizumab plus chemoradiotherapy (CRT) versus CRT or chemotherapy (CT) as the neoadjuvant treatment for patients (pts) with locally advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): A multicenter, randomized controlled, open-label, phase IIb study (TERRIFIC).(2026)
- → Temporal and spatial expression of CLDN18.2 in gastric cancer and gastroesophageal junction cancer.(2025)
- → Phase I trial of efficacy and safety of IMC002, a VHH-based anti-CLDN18.2 CAR-T therapy, for gastroesophageal cancers.(2026)
- → Chinese consensus on first-line precision therapy for advanced gastric cancer(2026)